Evidence map›Paper›PMID 23674175›Full record

ArticleEuropean journal of human genetics : EJHG2014

Expanding the phenotype of IQSEC2 mutations: truncating mutations in severe intellectual disability.

Frederic Tran Mau-Them, Marjolaine Willems, Beate Albrecht, Elodie Sanchez, Jacques Puechberty, Sabine Endele, Anouck Schneider, Nathalie Ruiz Pallares, Chantal Missirian, Francois Rivier and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in European journal of human genetics : EJHG, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Frontiers in pediatrics · 2026
    Article
  3. Natural Course ofChildren (Basel, Switzerland) · 2023
    Article
  4. Article
  5. Differences in Expression ofInternational journal of molecular sciences · 2022
    Article
  6. Frontiers in molecular neuroscience · 2022
    Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Next-generation sequencing in X-linked intellectual disability.European journal of human genetics : EJHG · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 9 institutions in 2 countries.

Frederic Tran Mau-ThemDepartement de Genetique Medicale, Centre de Reference Maladies Rares Anomalies du Developpement et Syndromes Malformatifs Sud-Languedoc Roussillon, Hopital Arnaud de Villeneuve CHRU Montpellier, Faculte de Medecine Universite Montpellier 1, Montpellier, France.
Marjolaine WillemsDepartement de Genetique Medicale, Centre de Reference Maladies Rares Anomalies du Developpement et Syndromes Malformatifs Sud-Languedoc Roussillon, Hopital Arnaud de Villeneuve CHRU Montpellier, Faculte de Medecine Universite Montpellier 1, Montpellier, France.
Beate AlbrechtInstitut fur Humangenetik, Universitatsklinikum Essen, Universitat Duisburg-Essen Hufelandstr, Essen, Germany.
Elodie SanchezDepartement de Genetique Medicale, Centre de Reference Maladies Rares Anomalies du Developpement et Syndromes Malformatifs Sud-Languedoc Roussillon, Hopital Arnaud de Villeneuve CHRU Montpellier, Faculte de Medecine Universite Montpellier 1, Montpellier, France.
Jacques PuechbertyDepartement de Genetique Medicale, Centre de Reference Maladies Rares Anomalies du Developpement et Syndromes Malformatifs Sud-Languedoc Roussillon, Hopital Arnaud de Villeneuve CHRU Montpellier, Faculte de Medecine Universite Montpellier 1, Montpellier, France.
Sabine EndeleHumangenetisches Institut Erlangen, Universitat Erlangen-Nurnberg, Erlangen, Germany.
Anouck SchneiderService de Genetique Chromosomique, Plateforme Puce a ADN, Hopital Arnaud de Villeneuve, CHRU Montpellier,Montpellier, France.
Nathalie Ruiz Pallares1] Service de Genetique Chromosomique, Plateforme Puce a ADN, Hopital Arnaud de Villeneuve, CHRU Montpellier,Montpellier, France [2] Laboratoire de Genetique, Unite Medicale des Maladies Auto-Inflammatoire, Hopital Arnaud de Villeneuve, CHRU Montpellier, Faculte de Medecine, Universite Montpellier, Montpellier, France.
Chantal MissirianDépartement de génétique médicale, Unité de génétique clinique, CHU de Marseille, Hôpital de la Timone, Marseille, France.
Francois RivierDepartement de Neuropediatrie, Hopital St Eloi, CHRU Montpellier, Montpellier, France.
Manon GirardService de Genetique Chromosomique, Plateforme Puce a ADN, Hopital Arnaud de Villeneuve, CHRU Montpellier,Montpellier, France.
Muriel HolderDepartement de Genetique, Hopital Jeanne de Flandre, CHRU Lille, Lille, France.
Sylvie ManouvrierDepartement de Genetique, Hopital Jeanne de Flandre, CHRU Lille, Lille, France.
Isabelle TouitouLaboratoire de Genetique, Unite Medicale des Maladies Auto-Inflammatoire, Hopital Arnaud de Villeneuve, CHRU Montpellier, Faculte de Medecine, Universite Montpellier, Montpellier, France.
Genevieve LefortService de Genetique Chromosomique, Plateforme Puce a ADN, Hopital Arnaud de Villeneuve, CHRU Montpellier,Montpellier, France.
Pierre SardaDepartement de Genetique Medicale, Centre de Reference Maladies Rares Anomalies du Developpement et Syndromes Malformatifs Sud-Languedoc Roussillon, Hopital Arnaud de Villeneuve CHRU Montpellier, Faculte de Medecine Universite Montpellier 1, Montpellier, France.
Anne MonclaDepartement de Neuropediatrie, Hopital St Eloi, CHRU Montpellier, Montpellier, France.
Severine DrunatUF de Genetique Moleculaire et de Biochimie, Pole Biologie et Pharmacie, CHU Robert Debre, APHP.
Dagmar WieczorekInstitut fur Humangenetik, Universitatsklinikum Essen, Universitat Duisburg-Essen Hufelandstr, Essen, Germany.
David GenevieveDepartement de Genetique Medicale, Centre de Reference Maladies Rares Anomalies du Developpement et Syndromes Malformatifs Sud-Languedoc Roussillon, Hopital Arnaud de Villeneuve CHRU Montpellier, Faculte de Medecine Universite Montpellier 1, Montpellier, France.
Génétique Médicale & Génomique Fonctionelle · FRHôpital Arnaud de Villeneuve · FRHôpital Saint Eloi · FRUniversity of Duisburg-Essen · DECentre Hospitalier Universitaire de Lille · FRFriedrich-Alexander-Universität Erlangen-Nürnberg · DEHôpital de la Timone · FRHôpital Jeanne de Flandre · FRHôpital Robert-Debré · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Intellectual disability (ID) is frequent in the general population, with 1 in 50 individuals directly affected worldwide. The multiple etiologies include X-linked ID (XLID). Among syndromic XLID, few syndromes present severe ID associated with postnatal microcephaly and midline stereotypic hand movements. We report on three male patients with ID, midline stereotypic hand movements, hypotonia, hyperkinesia, strabismus, as well as seizures (2/3), and non-inherited and postnatal onset microcephaly (2/3). Using array CGH and exome sequencing we characterised two truncating mutations in IQSEC2, namely two de novo intragenic duplication mapped to the Xp11.22 region and a nonsense mutation in exon 7. We propose that truncating mutations in IQSEC2 are responsible for syndromic severe ID in male patients and should be screened in patients without mutations in MECP2, FOXG1, CDKL5 and MEF2C.

Indexed as

Abnormalities, MultipleAdultChild, PreschoolCodon, NonsenseGenetic Association StudiesGenetic Predisposition to DiseaseGuanine Nucleotide Exchange FactorsHumansIntellectual DisabilityMalePhenotypeCodon, NonsenseGuanine Nucleotide Exchange FactorsIQSEC2 protein, human

Identifiers

PMID23674175
PMCPMC3895633
OpenAlexW2000448853

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.